A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

Research Programs

Frontiers in Oncology Seminars

2009 - 2010 Frontiers in Oncology Seminars

The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.

When: 3rd Wednesday of every month, 8:00 a.m.
Where:

University of Maryland Health Science Facility II (HSF II) Auditorium
20 S. Penn Street, Baltimore, MD 21201

(except November in Hosick Hall)

CME Credit: One (1)
Contact:

410-328-7516
Note: If you would like to meet with the speaker, please contact Florence Wade.

2009-2010 Seminar Schedule
September 16, 2009

Marius Sudol, Ph.D.
Adjunct Associate Professor
Staff Scientist
Weis Center for Research
Danville, PA

"From Src Oncogene to WW Domain: Deciphering the HIPPO Tumor Suppressor Pathway in Mammals"

At right: Dr. Antonio Passaniti (sponsor), Dr. Marius Sudol, and Dr. Kevin Cullen

From left:  Dr. Antonio Passaniti (sponsor), Dr. Marius Sudol, and Dr. Kevin Cullen
October 21

Yang-Xin Fu, M.D., Ph.D.
Professor, Department of Pathology
The University of Chicago
Chicago, IL

Dr. Fu's presentation was entitled "The Therapeutic Effect of anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity" and he presented on Wednesday, October 21, 2009.

At right: Dr. Scott Strome, and Dr. Yan-Xin Fu

Dr. Scott Strome, and Dr. Yan-Xin Fu
November 18

Merrill J. Egorin, M.D., FACP
Professor of Medicine and Pharmacology
University of Pittsburgh Cancer Institute
Room G27E, Hillman Research Pavilion
Pittsburgh, PA

"Oral Chemotherapy: Issues That My Generation of Oncologists Never Had to Think About"

At right: Dr. Merrill Egorin and Dr. Douglas Ross (sponsor)

Dr. Merrill Egorin and Dr. Douglas Ross (sponsor)
December 16

Danny R. Welch, Ph.D.
Leonard H. Robinson Professor of Pathology
Cell Biology and Pharmacology/Toxicology
Director, UAB Howard Hughes Med-to-Grad Graduate Program and UAB Cancer Biology Graduate Program
University of Alabama at Birmingham

At right: Dr. Anne Hamburger (sponsor), Dr. Danny Welch, and Dr. Dhan Kalvakolanu

Dr. Anne Hamburger (sponsor), Dr. Danny Welch, and Dr. Dhan Kalvakolanu
January 20, 2010

Jack Keene, Ph.D.
James B. Duke Professor
Department of Molecular Genetics and Microbiology
Duke University Medical Center
Durham, NC

"Coordinated RNA Dynamics in Cancer Cells"

At right: Dr. Bret Hassel (sponsor), Dr. Kevin Cullen and Dr. Jack Keene

Dr. Bret Hassel (sponsor), Dr. Kevin Cullen and Dr. Jack Keene
February 17

Steven M. Frisch, Ph.D.
Professor of Biochemistry and Molecular Pharmacology
West Virginia University
Robert C. Byrd Health Sciences Center

“A Novel Pathway for the Regulation of Anoikis by EMT"

At right: Dr. Stuart Martin (sponsor), Dr. Steven Frisch, Dr. Kevin Cullen

Dr. Stuart Martin (sponsor), Dr. Steven Frisch, Dr. Kevin Cullen
March 17

Larry Norton M.D.
Deputy, Physician-in-Chief for Breast Cancer Programs
Medical Director,
Evelyn H. Lauder Breast Center
Memorial Sloan-Kettering Cancer Center
New York, NY

"Self-Seeding: A New Model of Malignant Growth"

At right: Dr. Anne Hamburger, Dr. Larry Norton, Dr. Kevin Cullen

Dr. Anne Hamburger, Dr. Larry Norton, Dr. Kevin Cullen
April 21

Carl H. June, M.D.
Professor
Department of Pathology and Laboratory Medicine
University of Pennsylvania
Philadelphia, PA

"Adoptive T Cell Transfer Therapy: Genie Out of the Bottle?"

At right: Dr. Aaron Rapoport, Dr. Carl June, Dr. Kevin Cullen

Dr. Aaron Rapoport, Dr. Carl June, Dr. Kevin Cullen
May 19

Richard A. Van Etten, M.D., Ph.D.
Professor
Molecular Oncology Research Institute
Division of Hematology/Oncology
Tufts Medical Center
Boston, MA

"Insights into the Pathogenesis and Therapy of Myeloproliferative Neoplasms Through Studies in Mice"

At right: Dr. Richard Van Etten, Dr. Feyruz Rassool, and Dr. Kevin Cullen

Dr. Richard Van Etten, Dr. Feyruz Rassool, and Dr. Kevin Cullen
June 16

Vishva M. Dixit, M.D.
Vice President, Early Discovery Research
Genentech, Inc.
South San Francisco, CA

“Ubiquitin Modification in Cancer Signaling Pathways"

At right: Dr. Stuart Martin (sponsor), Dr. Vishva M. Dixit, Dr. Kevin Cullen

Dr. Stuart Martin (sponsor), Dr. Vishva M. Dixit, Dr. Kevin Cullen

This page was last updated on: August 27, 2013.